Global Regulatory requirements are very dynamic and becoming stringent with respect to the development, manufacturing, and distribution of biopharmaceutical products. Given the dynamic nature of regulations, medicinal products’ manufacturers are facing challenges in decoding and understanding the updated Regulatory compliance requirements, choosing the right Regulatory submission roadmap, and developing an appropriate Regulatory strategy to enter into the global markets.